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Authors’ reply Introduction We would like to 
thank Prof. Jankowski for his interesting com‑
ment1 to our article on blood pressure and cho‑
lesterol control in patients with hypertension 
and hypercholesterolemia, published in the De‑
cember issue of Polish Archives of Internal Medi-
cine (Pol Arch Intern Med).2 Although efficacious 
treatment for hypertension and hypercholester‑
olemia is available, achieving control over these 
2 modifiable risk factors is still a serious prob‑
lem not only in Poland but also in most oth‑
er countries as well.1,3 -5 Encouraged by Prof. 
Jankowski, we reanalyzed data of 2037 partic‑
ipants of the WOBASZ II (Multicenter National 
Population Health Examination Survey; Polish, 
To the editor I have read with great interest 
the new paper by Niklas et al.1 Indeed, the au‑
thors should be congratulated for another im‑
portant analysis of data from the WOBASZ II 
(Multicenter National Population Health Exam‑
ination Survey; Polish, Wieloośrodkowe Ogól‑
nopolskie Badanie Stanu Zdrowia Ludności). As 
hypertension and hypercholesterolemia are con‑
sidered the major factors influencing population 
health in developed countries, results of Niklas 
et al1 (only 5% of the participants had both blood 
pressure and cholesterol well controlled) should 
be seen as alarming.2
Niklas et al3 analyzed the potential reasons 
that could have been responsible for low con‑
trol rate of the 2 analyzed diseases. Accord‑
ing to the previously published data, 41% of 
the  WOBASZ II surveyed participants with 
hypertension were not aware of the disease. 
The corresponding proportion for hypercho‑
lesterolemia was 61%.4 Is it possible to present 
the proportion of the study participants with 
hypertension and hypercholesterolemia who 
were aware of the diseases? The proportion of 
the study participants not aware among those 
with uncontrolled hypertension and hypercho‑
lesterolemia would be of special interest. In‑
deed, if this proportion occurred to be high, it 
could be seen as another reason for more inten‑
sive screening programs in Poland. However, if 
the proportion was rather low, it would mean 
more emphasis should probably be given to coun‑
teract low adherence and persistence of patients 
as well as inertia of physicians.
Niklas et al1 showed that patients with cardio‑
vascular disease have a 2 ‑fold higher probability of 
well controlled hypertension and hypercholester‑
olemia. Although this figure agrees with the pre‑
viously published data from secondary preven‑
tion surveys, it should be highlighted that even 
among patients with the highest cardiovascular 
risk, that is, those with established coronary ar‑
tery disease, the control of risk factors is insuffi‑
cient.5 Considering all the available data, there is 
a considerable potential for reduction of cardio‑
vascular risk in Poland, and the preventive car‑
diology should become an important priority for 
the policymakers.
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of hypertension treatment only was achieved by 
20.2%, and another 4.9% achieved the goal of 
hypercholesterolemia treatment only. Over two‑
‑thirds of people (67.5%) with hypertension and 
hypercholesterolemia did not achieve any of the 2 
treatment goals.
Discussion An alarming conclusion from our 
findings is that only 7.4% of persons who had co‑
existing hypertension and hypercholesterolemia 
had both of these risk factors well controlled. 
It is obvious that the most important cause of 
the poor control of hypercholesterolemia and 
hypertension in Poland is insufficient detection, 
which is followed by a combined effect of wrong 
prescription practices, insufficient compliance 
to treatment, and drug intolerance. According 
to our previous report, less than 15% of patients 
treated for hypercholesterolemia were on high or 
moderate doses of statins.5 Effectiveness of hy‑
pertension control seems to be better, but still, 
about 77% of persons with hypertension do not 
achieve treatment goals.4
The prevalence of coexisting HT and hyper‑
cholesterolemia in about one ‑third of the general 
population2 and poor control of both risk factors 
in persons aware of having hypertension and / or 
hypercholesterolemia supports the recommenda‑
tion to use the single ‑pill combination of hypo‑
tensive and hypolipemic agents. However, it is 
important to remember that lifestyle modifica‑
tion, mainly maintaining desirable physical ac‑
tivity and diet, are the key factors that not only 
facilitate control of hypercholesterolemia and 
hypertension but also prevent their occurence.7
Conclusions The example of poor control of co‑
existing hypercholesterolemia and hyperten‑
sion calls for comprehensive national strategy 
of the prevention of cardiovascular disease, which 
would include lifestyle modification, detection of 
risk factors followed by an intensive efficacious 
intervention that would include the best avail‑
able pharmacological treatments.
Wieloośrodkowe Ogólnopolskie Badanie Stanu 
Zdrowia Ludności)6 study with coexisting hy‑
pertension and hypercholesterolemia to describe 
an interrelation between awareness and control 
of these conditions.
Results Detailed information on the awareness 
and control of hypertension and hypercholester‑
olemia is presented in TABLE 1.  Out of 2037 peo‑
ple with coexisting hypertension and hypercho‑
lesterolemia, 22.1% did not know that they had 
lipid and blood pressure  above the recommend‑
ed level. Out of 672 participants (33%) who were 
informed about having 1 of the 2 factors studied, 
about three ‑fourth had been informed on hyper‑
tension and about one ‑fourth on hypercholester‑
olemia. Among all participants informed about 
having hypertension (n = 1424), the percentage 
of those achieving hypertension treatment goals 
was higher than the percentage of persons achiev‑
ing hypercholesterolemia treatment goals among 
1078 participants informed about having hyper‑
cholesterolemia (39.5% and 23.3%, respective‑
ly). Out of 915 participants (30.5%) informed 
about having both hypertension and hypercho‑
lesterolemia, 44.3% achieved the goals of hyper‑
tension treatment, and 26.3% achieved the goals 
of hypercholesterolemia treatment. However, 
only 16.5% achieved treatment goals for both 
hypertension and hypercholesterolemia, and as 
much as 45.9% did not achieve any treatment 
goals. The effectiveness of treatment of the hy‑
pertension and hypercholesterolemia was high‑
er in participants informed about having both 
conditions as compared with those who were in‑
formed about having only 1. In participants in‑
formed about hypertension only, the goal for hy‑
pertension treatment was achieved by 30.8%, and 
in participants informed about hypercholesterol‑
emia only, the goal of hypercholesterolemia treat‑
ment was achieved by 6.1%.
In the entire sample (n = 2037), both treatment 
goals for hypertension and hypercholesterolemia 
were achieved only by 7.4%. Additionally, the goal 
TABLE 1 Awareness and control of hypertension and hyperlipidemia in the WOBASZ II participants with both conditions (age range, 19–99 years)
  Awareness
Neither HT nor HL HT only HL only HT and HL Total
n % n % N % n % n %
Control
Neither HT 
nor HL
n 450 32.7 352 25.6 153 11.1 420 30.5 1375 100
% 100 69.2 93.9 45.9 67.5
HT only n 0 0 157 38.2 0 0 254 61.8 411 100
% 0 30.8 0 27.8 20.2
HL only n 0 0 0 0 10 10 90 90 100 100
% 0 0 6.1 9.8 4.9
HT and HL n 0 0 0 0 0 0 151 100 151 100
% 0 0 0 16.5 7.4
Total n 450 22.1 509 25 163 8 915 44.9 2037 100
% 100 100 100 100 100
Abbreviations: HL, hypercholesterolemia; HT, hypertension
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